Related Experiment Video
Updated: Aug 30, 2026
Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
Published on: November 21, 2025
Effect of poly(ADP-ribose) polymerase inhibition on outer medullary hypoxic damage
David Darmon1, Marina Goldfarb, Ahuva Shina
1Renal Unit, Bikur Holim Hospital, Jerusalem, Israel.
Abstract:
Poly(ADP-ribose) polymerase (PARP) activation after free-radical-induced DNA damage depletes cellular energy stores and participates in ischemia-reflow injury. We studied the potential protective effect of the water-soluble PARP inhibitor 3-aminobenzamide (3-AB) in a rat model of acute renal failure (ARF) from combined administration of radiocontrast, indomethacin and N(omega)-nitro-L-arginine methyl ester. Kidney function at 24 h was better preserved in rats treated with 3-AB as compared to control animals. However, the extent of tubular hypoxic damage was not significantly mitigated. It is concluded that PARP inhibition may attenuate renal dysfunction in this model of ARF with medullary hypoxic tubular injury even while the extent of tubular necrosis is not significantly altered. Further studies of this dyssynchrony of structure and function may provide important insights into the sequence of events that promotes renal failure after medullary injury.
Insights
Poly(ADP-ribose) polymerase (PARP) inhibition with 3-AB protected kidney function in a rat model of acute renal failure. However, it did not significantly reduce tubular damage, suggesting a complex interplay in renal injury.
Area of Science:
- Biochemistry
- Nephrology
- Pharmacology
Background:
- Poly(ADP-ribose) polymerase (PARP) activation contributes to cellular energy depletion and ischemia-reflow injury following DNA damage.
- PARP activation plays a role in the pathophysiology of acute renal failure (ARF).
Purpose of the Study:
- To investigate the protective effects of the water-soluble PARP inhibitor, 3-aminobenzamide (3-AB), in a rat model of ARF.
- To assess the impact of PARP inhibition on kidney function and tubular injury.
Main Methods:
- A rat model of ARF was induced using radiocontrast, indomethacin, and N(omega)-nitro-L-arginine methyl ester.
- Rats were treated with either 3-AB or a control substance.
- Kidney function and the extent of tubular hypoxic damage were evaluated at 24 hours.
Main Results:
- Kidney function was significantly better preserved in rats treated with 3-AB compared to control animals at 24 hours.
- The extent of tubular hypoxic damage was not significantly mitigated by 3-AB treatment.
- A dissociation between improved renal function and unaltered tubular necrosis was observed.
Conclusions:
- PARP inhibition may attenuate renal dysfunction in this ARF model characterized by medullary hypoxic tubular injury.
- The findings suggest that PARP inhibition's protective effects on renal function occur independently of significant changes in tubular necrosis.
- Further research into the structural-functional dyssynchrony following medullary injury is warranted to understand renal failure progression.
